Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Effects of traditional Japanese massage therapy on various symptoms in patients with Parkinson's disease: a case-series study

Donoyama N, Ohkoshi N.

J Altern Complement Med. 2012 Mar;18(3):294-9. doi: 10.1089/acm.2011.0148. Epub 2012 Mar 2.

Thiamine and Parkinson's disease

Lu'o'ng Kv, Nguyên LT.

J Neurol Sci. 2012 May 15;316(1-2):1-8. doi: 10.1016/j.jns.2012.02.008. Epub 2012 Mar 2.

Evaluation of suspected right ventricular pathology in the athlete

Sniderman JD, Sado DM, Sniderman AD, McKenna WJ.

Prog Cardiovasc Dis. 2012 Mar-Apr;54(5):397-406. doi: 10.1016/j.pcad.2012.01.005.

Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction

Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED.

Pain. 2012 Apr;153(4):744-754. doi: 10.1016/j.pain.2012.01.002. Epub 2012 Mar 3.

Orbital and ventromedial prefrontal cortex functioning in Parkinson's disease: neuropsychological evidence

Poletti M, Bonuccelli U.

Brain Cogn. 2012 Jun;79(1):23-33. doi: 10.1016/j.bandc.2012.02.002. Epub 2012 Mar 3.

Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease

Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q.

Prog Neurobiol. 2012 Apr;97(1):1-13. doi: 10.1016/j.pneurobio.2012.02.002. Epub 2012 Feb 25.

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease

Bourque M, Dluzen DE, Di Paolo T.

Front Neuroendocrinol. 2012 Apr;33(2):169-78. doi: 10.1016/j.yfrne.2012.02.003. Epub 2012 Mar 1.

Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial

Pintor L, Valldeoriola F, Baillés E, Martí MJ, Muñiz A, Tolosa E.

Clin Neuropharmacol. 2012 Mar-Apr;35(2):61-6. doi: 10.1097/WNF.0b013e31824d5115.

Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results

van der Mark M, Brouwer M, Kromhout H, Nijssen P, Huss A, Vermeulen R.

Environ Health Perspect. 2012 Mar;120(3):340-7. doi: 10.1289/ehp.1103881.

Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson's disease

Hattori N, Hasegawa K, Sakamoto T.

J Clin Pharm Ther. 2012 Oct;37(5):571-7. doi: 10.1111/j.1365-2710.2012.01336.x. Epub 2012 Mar 6.

Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis

Rodday AM, Triedman JK, Alexander ME, Cohen JT, Ip S, Newburger JW, Parsons SK, Trikalinos TA, Wong JB, Leslie LK.

Pediatrics. 2012 Apr;129(4):e999-1010. doi: 10.1542/peds.2011-0643. Epub 2012 Mar 5.

Leucine-rich repeat kinase 2 for beginners: six key questions

Kett LR, Dauer WT.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a009407. doi: 10.1101/cshperspect.a009407.

Cranial and related sensorimotor impairments in rodent models of Parkinson's disease

Fleming SM, Schallert T, Ciucci MR.

Behav Brain Res. 2012 Jun 1;231(2):317-22. doi: 10.1016/j.bbr.2012.02.034. Epub 2012 Feb 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias